5-(4,9-METHANOCYCLOUNDECA-2',4',6',8',10'-PENTAENYLIDENE)-2,4-DIETHYLPYRIMIDINE-2(1H),4(3H),6(5H)-TRIONE
Compound with spectra: 1 NMR
| SpectraBase Compound ID | L2R412ztBke |
|---|---|
| InChI | InChI=1S/C20H20N2O3/c1-3-21-18(23)17(19(24)22(4-2)20(21)25)16-11-9-14-7-5-6-8-15(13-14)10-12-16/h5-12H,3-4,13H2,1-2H3/b11-9-,12-10- |
| InChIKey | YGPHMZGWEVYTOO-HWAYABPNSA-N |
| Mol Weight | 336.39 g/mol |
| Molecular Formula | C20H20N2O3 |
| Exact Mass | 336.147393 g/mol |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | Unknown |
1,3-diethyl-5-(2-oxolanylidene)-2-sulfanylidene-1,3-diazinane-4,6-dione
(5E)-1-(4-fluorobenzyl)-5-[(2E)-3-(2-furyl)-2-propenylidene]-2,4,6(1H,3H,5H)-pyrimidinetrione
(5E)-1-(4-methoxybenzyl)-5-[(2E)-3-phenyl-2-propenylidene]-2,4,6(1H,3H,5H)-pyrimidinetrione
(5E)-1-[2-(4-fluorophenyl)ethyl]-5-[(2E)-3-(2-furyl)-2-propenylidene]-2,4,6(1H,3H,5H)-pyrimidinetrione
(5E)-1-allyl-5-{1-[(3-hydroxypropyl)amino]ethylidene}-2,4,6(1H,3H,5H)-pyrimidinetrione
(5Z)-5-[(2E)-3-anilino-2-propenylidene]-1-cyclohexyl-2,4,6(1H,3H,5H)-pyrimidinetrione
(5E)-1-allyl-5-(1-{[3-(diethylamino)propyl]amino}ethylidene)-2,4,6(1H,3H,5H)-pyrimidinetrione
(5E)-1-allyl-5-[1-(hexylamino)ethylidene]-2,4,6(1H,3H,5H)-pyrimidinetrione
(5E)-1-allyl-5-(1-{[2-(dimethylamino)ethyl]amino}ethylidene)-2,4,6(1H,3H,5H)-pyrimidinetrione
(5Z)-1-allyl-5-(1H-benzimidazol-2-ylmethylene)barbituric acid
| Title | Journal or Book | Year |
|---|---|---|
| Novel Synthesis, Properties, and Oxidizing Ability of 11,13-Disubstituted 3,8-Methanocycloundeca[8,9-b]pyrimido[5,4-d]-furan-12(11H),14(13H)-dionylium Tetrafluoroborates | The Journal of Organic Chemistry | 2003 |
This compound is available in the following databases:
KnowItAll NMR Spectral Library
Author: Wiley
The KnowItAll NMR Spectral Library offers a comprehensive collection of NMR reference spectra, including NMR, CNMR, and XNMR, and covers a wide range of compounds including organics, polymers, monomers, metabolites, and more. Learn more.